Per-report vs subscription teleradiology pricing

"Do you bill monthly, or per study?" It is the question a buyer asks in the first ten minutes of a teleradiology pricing call, and the answer moves more of your annual spend than the headline rate does. Per-report pricing bills you for signed reports and nothing else, so the vendor carries the volume risk. A subscription bills a committed monthly figure whether the studies arrive or not, and hands you a lower per-study rate in exchange for carrying that risk yourself. Both models are legitimate. Which one is cheaper for your practice comes down to three things: your break-even utilization, your slowest month, and how fast you can get out.

This page is the head-to-head between those two structures. If you want the full taxonomy, including per-RVU and FTE-equivalent coverage blocks, read the four teleradiology pricing models. If you want dollar ranges by modality, read teleradiology cost per read. What follows is for the buyer with one quote of each kind on the desk and a decision due.

What a subscription quote buys you

A subscription buys a lower per-study rate, budget certainty, and in some contracts a reserved reader. What you give in return is a floor under the vendor's revenue. That floor is the product being sold, and every other term in the agreement exists to protect it.

Subscription quotes arrive in three shapes, and they behave very differently on an invoice.

The third shape is the one buyers underweight. A platform fee looks like infrastructure and reads like a rounding error on a busy month, which is exactly why it survives the negotiation. On a quiet month it is a minimum wearing a different coat.

The genuine advantages are real and worth naming. A commitment gives your finance team one number to forecast. It gives you negotiating room you do not otherwise have, because volume is the only currency most teleradiology sales teams accept. And where the contract names a dedicated radiologist on a dedicated shift, it buys continuity that a turnaround SLA does not describe: the same reader following the same oncologic service line every day is a clinical benefit, and it is priced as one.

Do teleradiology companies require volume minimums?

Many do, and the minimum is frequently the mechanism that makes a headline rate look competitive. A quoted price of X per study with a 1,200-study floor is not the same offer as the same price with no floor, and the two are routinely compared as though they were. Ask in writing. Get the answer in the contract.

Three questions separate a minimum you can live with from one that will hurt.

How is the shortfall calculated? Billing the gap at full list rate is the harshest version. Billing it at the discounted rate is softer. Stepping your rate up for the month is softer still, because it only costs you the discount.

Over what period is it reconciled? A monthly true-up punishes every quiet month independently. Quarterly or annual reconciliation lets a heavy March pay for a thin February, which for seasonal imaging volume can be worth more than a point or two on the rate.

Does unused volume carry forward, and does the credit expire? Rollover clauses exist. Most of them expire at the end of the contract year, which means a credit earned in month 11 is worth almost nothing.

If your volume is genuinely unpredictable, a minimum is a bet on a forecast you have already told yourself you cannot make. That is the situation overflow radiology reads and after-hours coverage put most facilities in, because the volume that gets outsourced is precisely the volume that refuses to sit still.

What per-report pricing buys you

Per-report pricing buys an invoice that matches your worklist. One fixed price per signed report, set by study type and priority tier, charged only when a radiologist signs. Send 400 studies and you are billed for 400. Send 4,000 and the per-study price is the same one you were quoted.

The model moves volume risk onto the vendor, which has a second-order effect worth understanding: the vendor now has to keep enough capacity staffed to absorb your spikes without a commitment from you, and that capacity has to be paid for out of the per-report rate. That is why per-report list prices sit above the discounted rate inside a large commitment. You are paying for elasticity, and elasticity is not free.

Be honest about the trade-offs. Per-report pricing gives your finance team a variable line item. It does not, on its own, buy you a named individual at a workstation between 10pm and 6am. And at genuinely high, flat volume, an unnegotiated per-study rate will lose to a well-negotiated commitment on the annual total. A vendor who will not concede that is selling you something.

Which model wins at your volume?

Neither model wins at a volume. A subscription wins at a utilization rate, and the rate is one minus the discount. If a commitment cuts your per-study price by 15%, you break even when you actually send 85% of the committed volume, and every month below that line costs you more per signed report than plain per-report pricing would have.

That single relationship is the whole comparison, and it survives the fact that almost nobody in this market publishes sticker rates. Call your per-report list price B for the same study mix. The table below shows what a commitment costs you at three utilization levels, expressed in multiples of B.

Read the last column first. A 30% discount, which is an aggressive concession in this market, is worth exactly nothing if you consistently consume 70% of what you committed to. Everything above that row is a loss at 70% utilization.

So the question to take into the negotiation is not what volume you average. It is what percentage of the commitment you cleared in your worst month of the last 24, and how many of those 24 months fell below the break-even line. Two facilities with identical annual volume can land 20% apart on effective cost purely on the shape of their monthly distribution. Pull the counts. The exercise takes an afternoon and it is the only version of this comparison that describes the year you are about to have.

The quiet month and the spike month, priced side by side

Run one commitment through four months and the pattern is obvious. Assume a 1,000-study monthly commitment at a 15% discount, overage billed at list, and B as your per-report list price for the same mix.

The spike month is where subscriptions often perform well, and a fair comparison has to say so: the discounted base plus list-rate overage still beat straight per-report pricing in that last row. The failure mode is the quiet month, where a 15% discount turned into a 42% premium on a month nobody planned for. Add a surge multiplier on overage, which several contracts carry, and the spike row degrades too.

Per-report pricing produces the same effective cost in all four rows. That is the entire proposition: 1.00 B in a quiet month, 1.00 B in a spike, no shortfall billing and no surge premium. The constraint is on the vendor's side, because absorbing a spike without a surcharge only works if the capacity genuinely exists. Ask any vendor quoting per-report pricing how much headroom they hold and how they measure it. AstraRad holds room for 25,000 additional studies a month with no waitlist, which is the number that makes a no-surge-premium claim mean something.

The contract terms that decide the real number: minimums, escalators, exit

Four clauses move your effective cost more than the rate does: how the minimum is enforced, what the annual escalator does to year two and three, how long the term runs, and what it costs to leave. Price the quote with all four applied, or you have priced a different agreement than the one you are signing.

Now the part that decides most disputes, and it is worth reading slowly. Minimums are almost never enforced the way the sales conversation implies. The quote says a 1,000-study commitment at a discounted rate, and the buyer hears a target. The agreement says the shortfall between committed and actual volume is invoiced monthly at the standard rate, which is a different sentence entirely. Between those two readings sits the reconciliation period, which is usually one line in a schedule instead of a headline term. A monthly true-up bills every quiet month on its own, so a year with four soft months carries four shortfalls even if the annual total cleared the commitment comfortably. An annual true-up nets the whole year and can produce zero shortfall on identical volume. Rollover clauses sit somewhere in between, and their value depends almost entirely on when the credit expires. If your seasonal pattern is a slow summer and a heavy fourth quarter, annual reconciliation may be worth more to you than another two points off the rate, and it is far easier to win in a negotiation because it costs the vendor nothing in a year you hit your number. Ask for it explicitly, in the same email as the rate request, then read what comes back with the same care you gave the rate.

Exit terms deserve equal attention because they set the cost of being wrong. A commitment you can leave on 90 days notice is a modest bet on your own forecast. The same commitment on a three-year term with a compounding escalator and an early termination fee is a much larger one, and the discount that justified it was quoted against year one volume. If you are already in that position, switching teleradiology providers walks through the sequence that keeps coverage intact while the notice period runs.

How to convert either quote to a cost per signed study

One number makes two structurally different quotes comparable: effective cost per signed study, computed on 12 months of your own volume, with every fee and multiplier applied. Everything else is a rate you will not actually pay.

The method is mechanical. Pull 24 months of study counts by modality and priority. Apply each vendor's complete structure to every month individually, never to the annual total alone, because that is where minimums and shortfalls express themselves. Include the fixed charges, all of them: platform and portal access, per-facility fees, integration or VPN charges, credentialing fees, and any onboarding cost. Apply the priority multiplier to your real STAT and urgent share, not to an assumed one. Add the escalator for years two and three if the term runs that long. Then divide total cost by total signed studies, and run the same arithmetic on your single worst month.

Two sanity checks are worth the extra hour. First, benchmark the implied per-study price against the professional component of the Medicare fee schedule for the CPT codes you actually send; the underlying work, practice expense, and malpractice values are published in the CMS Physician Fee Schedule relative value files, which is a defensible floor even though it prices interpretation work alone and says nothing about overnight availability, subspecialty routing, or an enforceable turnaround commitment. Second, confirm that the quote covers final signed reports at every tier, since a low per-study figure sometimes buys a preliminary interpretation that gets read again, and billed again, in the morning.

Then ask both vendors for the same three documents: a complete written rate card covering every study type, every priority and after-hours multiplier stated in writing, and a list of every charge that lives off the rate card. A vendor who supplies all three has made your comparison possible. One who supplies two has answered a different question, and verifying vendor claims covers how to test the rest of what you were told.

Where AstraRad sits, and when a subscription is the better buy

AstraRad prices per signed report. No minimums, no subscriptions, no platform or PACS access fees, no per-seat charge, and no onboarding or integration fee. STAT and urgent studies carry a fixed multiplier printed on the rate card and itemized on every invoice line. The agreement runs month to month with 30 days notice, and a complete written rate card arrives within one business day of a request.

You select the turnaround tier per study, and the published tiers are STAT under 1 hour, urgent under 4 hours, and routine under 24 hours, measured from last-image arrival to radiologist signature. Every study is routed by modality and body part to a board-certified, fellowship-trained subspecialist licensed in the state where your patients are, and every report is final and physician-signed. The full model, including the committed-volume discount ladder, sits on the AstraRad pricing page.

Here is the part a sales page usually omits. A subscription is the better buy when three conditions hold together: your volume is high, your monthly distribution is flat, and your slowest month in the past 24 still cleared the break-even utilization for the discount on offer. It is also the better buy when what you need is a person on a shift rather than a turnaround commitment, which is a staffing question and is priced like one; locum radiologist coverage compared with teleradiology sets out that calculation, and in-house versus outsourced radiology covers the version where the alternative is a hire. And it is the better buy when your finance function values a fixed budget line above a lower average cost, which is a legitimate institutional preference and not a mistake.

If none of those describe you, the commitment is buying certainty for the vendor and volatility for you. Run the break-even utilization against your own 24 months first. Then ask us for the written rate card and put a per-report structure in the same spreadsheet as the subscription quote, on your real months, including the quiet ones.